Header Logo

Oren Schaefer

Concepts (63)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pneumonia
2
2005
279
0.220
Why?
Suppuration
1
2003
11
0.210
Why?
Mycobacterium avium Complex
1
2003
3
0.210
Why?
Mycobacterium avium-intracellulare Infection
1
2003
8
0.210
Why?
Respiratory Tract Infections
1
2003
83
0.200
Why?
Bacterial Infections
1
2003
143
0.190
Why?
Cough
1
2003
183
0.180
Why?
Angioedemas, Hereditary
1
2010
5
0.090
Why?
Complement C1 Inhibitor Protein
1
2010
6
0.090
Why?
Complement Inactivating Agents
1
2010
13
0.090
Why?
Severity of Illness Index
2
2005
1511
0.080
Why?
Mianserin
1
2005
3
0.060
Why?
Oxazolidinones
1
2005
14
0.060
Why?
Serotonin Syndrome
1
2005
9
0.060
Why?
Acetamides
1
2005
13
0.060
Why?
Citalopram
1
2005
19
0.060
Why?
Triage
1
2005
112
0.060
Why?
Urticaria
1
2004
7
0.060
Why?
Antidepressive Agents
1
2005
230
0.060
Why?
Hypothermia, Induced
1
2004
41
0.050
Why?
Cold Temperature
1
2004
51
0.050
Why?
Patient Admission
1
2005
191
0.050
Why?
Immunocompetence
1
2003
21
0.050
Why?
Bronchoscopy
1
2003
84
0.050
Why?
Aortic Valve
1
2004
174
0.050
Why?
Coronary Artery Bypass
1
2004
278
0.050
Why?
Heart Valve Prosthesis Implantation
1
2004
157
0.050
Why?
Intensive Care Units
1
2005
455
0.050
Why?
Radiography
1
2003
520
0.050
Why?
Diagnosis, Differential
1
2003
932
0.040
Why?
Middle Aged
4
2005
16857
0.040
Why?
Chronic Disease
1
2003
756
0.040
Why?
Anti-Bacterial Agents
1
2005
747
0.040
Why?
Female
5
2010
31706
0.040
Why?
Adult
3
2010
16211
0.030
Why?
Aged
3
2005
13873
0.030
Why?
Humans
6
2010
60913
0.030
Why?
Male
4
2010
28424
0.020
Why?
Adolescent
1
2003
6041
0.020
Why?
Retrospective Studies
1
2003
6192
0.020
Why?
Ultrafiltration
1
2010
13
0.020
Why?
Cross-Over Studies
1
2010
155
0.020
Why?
Infusions, Intravenous
1
2010
174
0.020
Why?
Nanotechnology
1
2010
129
0.020
Why?
Analysis of Variance
1
2010
593
0.020
Why?
Proportional Hazards Models
1
2010
690
0.020
Why?
Acute Disease
1
2010
672
0.020
Why?
Double-Blind Method
1
2010
739
0.020
Why?
Linezolid
1
2005
7
0.020
Why?
Protein Synthesis Inhibitors
1
2005
25
0.020
Why?
Drug Synergism
1
2005
134
0.020
Why?
Bone Marrow Transplantation
1
2005
139
0.020
Why?
Transplantation, Homologous
1
2005
246
0.020
Why?
Urinary Tract Infections
1
2005
79
0.010
Why?
Community-Acquired Infections
1
2005
90
0.010
Why?
Rewarming
1
2004
7
0.010
Why?
Leukemia, Myeloid, Acute
1
2005
171
0.010
Why?
Sensitivity and Specificity
1
2005
1125
0.010
Why?
Pilot Projects
1
2005
944
0.010
Why?
Child
1
2010
4380
0.010
Why?
Risk Assessment
1
2005
1958
0.010
Why?
Aged, 80 and over
1
2005
5289
0.010
Why?
United States
1
2005
7657
0.010
Why?
Schaefer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (63)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_